Drug record
What four public record sets show for rosuvastatin. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.032 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $468.5 million | Details |
| FDA recall records | 13 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Rosuvastatin Calcium 5 Mg Tab: pharmacies pay about $0.032 each, or $0.947 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| ROSUVASTATIN CALCIUM 10 MG TAB | Generic | $0.036 per each | $1.07 | Oct 28, 2026 |
| ROSUVASTATIN CALCIUM 20 MG TAB | Generic | $0.046 per each | $1.39 | Oct 28, 2026 |
| ROSUVASTATIN CALCIUM 40 MG TAB | Generic | $0.069 per each | $2.08 | Oct 28, 2026 |
| ROSUVASTATIN CALCIUM 5 MG TAB | Generic | $0.032 per each | $0.947 | Oct 28, 2026 |
| CRESTOR 10 MG TABLET | Brand | $8.81 per each | $264.18 | Oct 21, 2026 |
| CRESTOR 20 MG TABLET | Brand | $8.80 per each | $264.04 | Oct 21, 2026 |
| CRESTOR 40 MG TABLET | Brand | $8.81 per each | $264.28 | Oct 21, 2026 |
| CRESTOR 5 MG TABLET | Brand | $8.81 per each | $264.41 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $468.5 million for the 3 products below. That is down 21% from $596.1 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Rosuvastatin Calcium Rosuvastatin Calcium | $436.6 million | 8,211,366 | $14.17 | $53.17 | $541.5 million |
| Crestor Rosuvastatin Calcium | $31.9 million | 13,827 | $584.99 | $2,308.52 | $54.4 million |
| Ezallor Sprinkle Rosuvastatin Calcium | $5,987 | 30 | $157.56 | $199.58 | $172,436 |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 13 recall records that name rosuvastatin in the product description (13 Class II). 4 are still marked ongoing.
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
Reason: Out of specification for dissolution.
Rosuvastatin Tablets 40mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-264-30
Reason: CGMP Deviations
Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Reason: cGMP Deviations
Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00.
Reason: cGMP Deviations
Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.
Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00
Reason: cGMP Deviations
Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Reason: cGMP Deviations
Rosuvastatin Tablets, USP 20 mg* Rx Only, Packaged as: a) 90-count bottle NDC 16729-286-15, UPC 3 16729 28615 2; b) 1,000-count bottles NDC 16729-286-17, UPC 3 16729 28617 6; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA
Reason: CGMP Deviations: recalling drug products following an FDA inspection.
Rosuvastatin Tablets, USP 40 mg* Rx Only, Packaged as: a) 30-count bottle NDC 16729-287-10, UPC 3 16729 28710 4; b) 90-count bottle NDC 16729-287-15, UPC 3 16729 28715 9; c) 1,000-count bottle NDC 16729-287-17, UPC 3 16729 28717 3; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA
Reason: CGMP Deviations: recalling drug products following an FDA inspection.
Rosuvastatin Tablets, USP, 10 mg*, Rx Only, Packaged as: a) 90-count bottle, NDC 16729-285-15, UPC 3 16729 28515 5; b) 1,000-count bottle NDC 16729-285-17, UPC 3 16729 28517 9; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA
Reason: CGMP Deviations: recalling drug products following an FDA inspection.
Rosuvastatin Tablets, USP, 5 mg*, Rx Only, Packaged as: a) 90-count bottle, NDC 16729-284-15, UPC 3 16729 28415 8; b) 1,000-count bottle, NDC 16729-284-17, UPC 3 16729 28417 2; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA.
Reason: CGMP Deviations: recalling drug products following an FDA inspection.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for rosuvastatin. This page is public-record information, not medical advice.